RecruitingACTRN12609000060246

Two new tests, Multiple Breath Washout Technique and Acoustic Severe Asthma Monitor, to measure lung function (breathing) in young children

Assessment of Lung Function Using the Multiple Breath Washout Technique and Acoustic Severe Asthma Monitor in Pre-School Children with a History of Wheezing


Sponsor

Murdoch Children Research Institute

Enrollment

100 participants

Start Date

Jan 27, 2009

Study Type

Observational

Conditions

Summary

Recent advances in diagnostic technologies and subsequent physiological research has lead to a number of techniques being widely available for use in the pre-school age group and resulted in the transition of these techniques into clinical practice. The use of these newer respiratory function techniques to assess airway function in pre-school children with recurrent wheeze may have major implications for our understanding of the pathophysiology of asthma.


Eligibility

Sex: Both males and femalesMin Age: 3 YearssMax Age: 6 Yearss

Inclusion Criteria1

  • child is between 3 and 6 years of age and has been referred to the hospital because of wheeze

Exclusion Criteria1

  • has another respiratory problem such as cystic fibrosis

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

There are two new tests that can be used to measure lung function in young children. These are called the multiple breath washout (MBW) and Acoustic Severe Asthma Monitor (ASAM). The MBW equipment is

There are two new tests that can be used to measure lung function in young children. These are called the multiple breath washout (MBW) and Acoustic Severe Asthma Monitor (ASAM). The MBW equipment is registered in Australia for use in children from birth. This system uses a multiple-breath washin/washout technique using sulphur-hexafluoride (SF6) as a tracer gas and a commercially available, TGA approved, ultrasonic flowmeter which indirectly measures inert tracer gas concentrations by continuous mainstream recording of the molar mass of the gas. The ASAM is a new breathing test and is not yet registered in Australia so its use is experimental. The ASAM is a combination of two technologies; incorporating both passive and active methods for continuous monitoring of the asthmatic patient. The passive technology employs the detection of wheezes and coughing in the patient. The active technology, which injects sound into the upper airways, monitors the degree of occlusion of intrapulmonary airways that occurs during asthma attacks. All participants undergo both tests in one session, with devices assigned in random order. Particpants will not have follow up as part of the study but will follow usual care. 50 children who wheeze and 50 children who don’t wheeze and have no other breathing problems shall be recruited and closeout shall occur within a year of commencement


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000060246


Related Trials